NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its second quarter revenues rose 4 percent year over year, falling slightly short of the consensus Wall Street estimate.

The company's total revenue for the three months ended March 31 was $85.5 million, compared with $82.0 million in the second quarter of 2016. Analysts on average had predicted revenues of $86.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.